An overview of phosphodiesterase 4 inhibitors in the treatment of rheumatic autoimmune diseases
LIU Ye-ling
ZHENG Wen-jie
Keywords：phosphodiesterase 4 inhibitorsrheumatic autoimmune diseasesmechanismefficacysafety
Publication Date：2023-11-30
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：6( 2240-2245 )